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The Sustainable Development Goals [SDGs] have specific aims to reduce maternal 
mortality and achieve gender equality. Whilst a significant amount of literature 
focuses on lower-income countries that have higher mortality and morbidity rates 
than the United Kingdom [UK], the UK must not be complacent. Maternal mortality 
and morbidity can still be improved nationally by critically evaluating whether the 
almost ubiquitous use of interventions in obstetric units is a contributory factor. 
Labour augmentation with oxytocin is not without risk and this therefore raises the 
question why maternity care is not incorporated into the gender equality goals in the 
UK. At its most basic level it could lead to a lack of informed consent, but is 
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Key points 
• Oxytocin augmentation is widespread, yet women are not always informed of 
its risks.  
• Definitions on active labour lack international consensus, making international 
comparisons on dystocia challenging. 
• The use of the partogram is based on weak evidence yet it influences the use 
of oxytocin.  
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• Although the UK has a lower maternal mortality rate than other countries, 
more needs to be done to prevent morbidity and mortality from ‘too much, too 
soon’. 
• Midwives require support, confidence, and experience to promote 
physiological births. 
• The risk discourse is inadvertently and ironically increasing the likelihood of 
interventions. 
 
Introduction and background 
The World Health Organization [WHO] (2019a) reported a 38% reduction in 
worldwide maternal mortality rate between 2000-2017 and a 50% reduction in 
neonatal mortality rate between 1990-2018 (WHO 2019b). Whilst this is a positive 
improvement, it still falls below the Millennium Development Goal target of a 75% 
reduction in maternal mortality by 2015 (WHO 2015), which has led to the revised 
Sustainable Development Goals [SDGs] (UN 2015a). The highest maternal and 
neonatal mortality rates continue to be in lower-income countries, in particular Sub-
Saharan Africa accounts for 66% of maternal deaths (WHO 2019c), whereas the 
maternal mortality in high-income countries is lower. In most European countries the 
maternal mortality rate is under 10:100,000 (Euro-Peristat 2018), with the UK 
reporting 9.2:100,000 (Knight et al. 2019). Despite the criticism that mortality 
worldwide cannot be adequately measured due to differing definitions and reporting 
methods (Bouvier-Colle et al. 2012; Euro-Peristat 2018; WHO 2019c), the 
inadequacies would not preclude high-income countries having the lowest rates. 
Whilst high-income countries can be praised for maternity care provision that results 
in low mortality rates, criticism has been made of over-medicalised practice, where 
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non-evidence based care causes harm and instigates disrespect and abuse (Shaw 
et al. 2016); this care has become known as ‘too much, too soon’ [TMTS].  
This paper will critically explore the impact of labour augmentation with oxytocin from 
the perspective of TMTS, questioning whether its widespread usage is helpful in 
meeting the global targets set out in the SDGs (UN 2019).  Although it is 
acknowledged that there are times when augmentation is necessary, it needs to be 
considered why a potentially harmful drug, whose effects are not fully understood, is 
being administered so readily for a physiological process and whether it is in line with 
global goals and guidance. The use of oxytocin as an ecbolic agent varies from 
country to country (Seijmonsbergen-Schermers et al. 2020), as such it is not 
unreasonable to question whether it is always necessary and consider the factors 
that influence its extensive use. 
 
SDGs, the UK and augmentation 
Women are marginalised worldwide, yet an educated, healthy and safe mother will 
enable her child to thrive, having a positive causal effect on future generations (Save 
the Children 2015), thus global initiatives relating to mothers and children are 
necessary. Both the unsuccessful Millennium Development Goals and the 
subsequent SDGs incorporate goals relating to maternal and child health, specifically 
a drive to reduce the maternal mortality rate, asserting the importance of skilled birth 
attendants (UN 2019). However, it should be noted that a large proportion of the 
preventable deaths in the UK are outside of the intrapartum period, with suicide 
being the leading cause of maternal death up to a year postpartum (Knight et al. 
2019). Additionally, the UK maternal mortality rate is challenged by race, with Black, 
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Asian and minority ethnic women having a higher mortality rate; black women only 
account for 4% of births yet they are five times more likely to die than white women 
(Knight et al. 2019). Thus, whilst the SDGs maternal mortality reduction target 
focuses on the use of skilled birth attendants, it is not specific to UK care. The UK 
needs review why Black, Asian and minority ethnic women are dying and develop 
appropriate goals.  
The focus on reducing global mortality is undoubtedly necessary, but it should be 
recognised that high income countries with low rates are challenged in preventing 
TMTS and need improved focus on the Gender Equality SDG. Gender inequality is 
evident worldwide. Women are disadvantaged in education, financial and political 
status (UN 2015b). The key indicator for achieving this SDG (legal frameworks to 
prevent discrimination) already exists in the UK and the Department for International 
Development (2019) has outlined further UK specific objectives. However, none of 
these objectives relate to maternal health, where it could be challenged that 
discrimination based on gender still exists. Unnecessary labour augmentation could 
be presented as an example of discrimination, where a need to accelerate a 
physiological process shows that intrapartum care is based on medical pathology, 
supporting Hill’s (2019) assertion that women’s bodies have been presented unfit for 
childbirth. In addition, poorly consented labour augmentation has been recognized 
as an example of violating women’s rights (Windau-Melmer 2013). NICE (2014) 
states a woman should be informed that oxytocin administration will shorten labour 
but change no other outcomes. It is therefore worthwhile considering the possible 
effects of oxytocin and whether NICE (2014) is promoting inadequate consent, thus 
violating the rights of women. In view of this, the SDGs do not go far enough in their 
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indicators for gender equality- there are no targets specifically aimed at defending 
the rights of women in maternity.  
 
Effects of oxytocin augmentation 
Oxytocin administration is recommended by WHO (2014) and NICE (2014) to 
augment labour when there is confirmed delay. However, oxytocin is a potentially 
dangerous drug, responsible for maternal and fetal deaths prior to the 
standardization of administration (Oláh and Steer 2015). Clark et al. (2009) suggest 
that even with current technology, it is not possible to prevent harm, as there is no 
method of accurately measuring its effects.  Whilst is may be argued that statement 
is imprecise, with internal tocodynamometry considered to be the most sensitive 
method of monitoring contractions (Cohen 2017), it is not without risk (Bakker et al. 
2010). Bakker et al’s. (2013) Cochrane Review concluded that there is insufficient 
evidence to recommend the use of one form of tocodynamometry over another. 
According to the Cochrane Review of Bugg et al. (2013), oxytocin administration for 
progress delay in spontaneous labour, compared to none or delayed administration, 
made no difference to the number of caesarean sections, nor adversely affected 
mother or baby, whilst shortening the length of labour by two hours. Research 
succeeding this has explored the potential adverse effects of oxytocin. A large 
(n=1,441,712) Norwegian population-based study, spanning 40 years (Al-Zirqi et al. 
2015), found an increase in uterine rupture over time, associated in part to an 
increase in augmentation with oxytocin for both nulliparous and multiparous women. 
Labour augmentation with oxytocin has also been associated with increased labour 
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pain (Khajehel 2017), less resting time between contractions (Aye et al. 2014) and 
hyperstimulation, along with associated fetal asphyxia (WHO 2014).  
Further research has explored long-term effects of oxytocin, that does not appear to 
be considered in Bugg et al. (2013). Gu et al’s. (2016) longitudinal study examining 
the long-term effects of oxytocin administration, found a correlation with oxytocin use 
and a reduction in breastfeeding rates. This supported the pilot study of Fernández 
et al. (2012), suggesting that intrapartum oxytocin disturbs the neonatal suckling 
reflex and therefore potentially affects breastfeeding success. In addition to this, Gu 
et al. (2016) found a positive correlation between oxytocin and postpartum 
depression. It is important to acknowledge that the findings were correlational not 
causal, however they are strengthened by Kroll-Desrosiers et al’s. (2017) population-
based study, which found an increased risk of postpartum depression and anxiety 
with intrapartum oxytocin use. Whilst the study compared a large data set (n=46,432) 
it was limited by the lack of data analysis on the indications for oxytocin and did not 
consider family history of mental health. In contrast, Takács et al. (2018) discredits 
both, finding exogenous oxytocin caused a lower risk of postpartum depression. 
Whilst all the studies have limitations, these are important possible associations to 
consider when the negative impact of postpartum depression on the mother-infant 
dyad, breastfeeding and the child’s future mental health is well known.  
 
Extent of oxytocin augmentation 
Despite the known and possible adverse effects of oxytocin for labour augmentation 
it is frequently administered. De Jonge et al’s. (2017) population-based study 
reported 34.3% of nulliparous women birthing in an obstetric unit in England were 
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augmented. Recent statistics are absent. The National Health Service [NHS] (NHS 
Digital 2019) maternity statistics do not report labour augmentation and recent audits 
have identified that data in many trusts has not met quality standards (NMPA Project 
Team 2019), a surprising finding considering the UK is highly regarded for maternity 
data collection (Knight et al. 2014). Other high-income countries have also reported 
high rates of augmentation. Seijmonsbergen-Schermers et al’s. (2020) multi-national 
cross-sectional study accounted for varying data quality and found labour 
augmentation in nulliparous women ranging from 21.7% (Ireland) to 70.9% (Finland).  
 
The partogram and its relationship to progression 
Evidence-based guidelines have been incorporated into WHOs (2016:16) 
“Framework for the quality of maternal and newborn health”, reinforcing Miller et al’s. 
(2016) suggestion that guidelines support prevention of TMTS. However, this is 
reliant on the guidelines being created from strong evidence. There is a need for a 
standardised definition of active labour, physiological labour progress and the use of 
a partogram in defining dystocia. The UK utilizes the NICE (2014:19) definition of 
active labour- “progressive cervical dilation from 4cm” with regular painful 
contractions. Aside from this definition relying on the assumption that all women 
request a vaginal examination (a practice itself which requires further research as to 
its efficacy (Downe et al. 2013)), there is no clear graded evidence for this definition 
(NICE 2006).  Abalos et al’s. (2018) systematic review studying spontaneous labour 
duration in low-risk women, reports global ambiguity in the definition of active labour 
throughout the 37 studies reviewed from low, middle, and high-income countries. 
Suggested cervical dilatation ranged from 1.5cm to 5cm, thus Abalos et al. (2018) 
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propose that without a worldwide definition of active labour, expected labour 
progress cannot be defined. Despite global ambiguity, WHO (2014) strongly 
recommend the use of a four-hour action line partogram for women in all settings, 
advising oxytocin for augmentation when that line is crossed (however they 
acknowledge this recommendation is based on weak evidence and there is no 
universal definition for labour delay). More recently, WHO (2018) guidelines suggest 
progress in labour may not accelerate before 5cm dilation, anticipating this 
recommendation to decrease medical intervention, but an alternative partogram has 
not been published. Lavender et al’s. (2018) Cochrane Review, states effects of 
routine partogram use is uncertain and requires further research. However, 
Juhasova et al. (2018: 63) assert research for a partogram truly suited to 
physiological labour requires the involvement of large numbers of women that have 
no obstetric intervention, stating “in contemporary obstetrical care, such an ideal 
situation is an illusion”. This suggests reducing TMTS through research exploring 
labour physiology is limited. Despite this, it needs to be acknowledged that global 
guidelines surrounding labour augmentation are built on insubstantial evidence and 
this needs to be addressed.  
 
The impact of epidemiology on the risk discourse 
The epidemiology of pregnant women in the UK presents a challenge. Whilst births 
for women under 20 have more than halved in England and Wales over the last 20 
years, births for women over 30 have steadily increased (NHS Digital 2019). 
Increasing age is associated with a rise in obesity (PHE 2019), diabetes, and 
caesarean sections (NHS Digital 2019; NHS Digital 2020). Obesity can have a 
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resultant negative impact on the mother, foetus, and the child’s future health (Davies 
2015). Women over the age of 40, like obese and diabetic women, are placed on a 
‘high risk’ care pathway (NICE 2008). Whilst the concept of risk discourse is widely 
discussed in maternity care (Scamell et al. 2019), it is too broad to address within 
this paper – however it needs to be acknowledged that the concept of risk could 
challenge preventing TMTS in the UK. An increasing trend of ‘high-risk’ pregnancies 
would theoretically result in a high percentage of obstetric unit births. However, 
Walsh et al. (2020) state approximately 45% of women in England are deemed ‘low 
risk’ at the end of their pregnancy, women who should be supported to birth in a 
midwifery unit or at home, where interventions are minimal in comparison to an 
obstetric unit (Birthplace in England Collaborative Group 2011). Nevertheless, Walsh 
et al. (2020) report that in 2012 only 11% of births in England occurred in a midwifery 
unit and 2% at home. Therefore, it could be postulated that it is not just epidemiology 
of pregnant women that presents a challenge to reducing TMTS, but also additional 
factors such as the UK maternity care model and the ability of those working in it to 
promote physiological processes.  
 
Physiologic birth – rhetoric or achievable reality? 
The Lancet series on Midwifery included a comprehensive review of midwifery 
(Renfrew et al. 2014), presenting a multi-dimensional framework for quality care, 
including components such as promotion of physiology and competent care 
providers. The framework has since been used to influence various policies and 
reports (NMC 2019a; UNFPA 2014; Renfrew and Hoope-Bender 2019) highlighting 
the importance of available, accessible and acceptable health care professionals. 
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Renfrew et al. (2014: 1131) highlights that the midwife promotes “normal processes”. 
However, Wagner (2001) asserts healthcare professionals who have only 
experienced high-intervention care, will not be able to reflect on its impact and 
change practice accordingly. This stance is supported by Coddington et al’s. (2020) 
qualitative study, exploring how exposure to homebirths affects the attitudes of 
midwives. Coddington et al. (2020) observed that homebirth enables midwives to 
better understand physiological birth, which subsequently positively changed their 
practice in an obstetric unit. Although carried out in Australia, the similarities in the 
high volume of obstetric unit births indicate findings are transferable to the UK. 
Therefore, it needs to be considered if current UK maternity care enables midwives 
to promote physiology to reduce interventions, such as labour augmentation. If not, 
then it could be questioned if the Nursing and Midwifery Council [NMC] (2019a) 
standards, that include optimising physiological processes as part of the key themes, 
can be truly upheld. If midwives are not competent in, or supported to promote 
physiology, this could have resultant detrimental effects on the education of student 
midwives. In essence, the disembodied normality paradigm replaced by the 
‘superior’ obstetric knowledge (Spendlove 2018), perpetuated as a cultural norm. 
Education institutions will be challenged to find ways to ensure students experience 
physiologic birth as outlined by the NMC (2019b). It could be proposed that until the 
structure of UK maternity care changes and there is greater access to and utilization 
of midwifery units and homebirths for women, midwives, and students, that the 







To change the structure of maternity care, there needs to be consideration of how 
policy, midwifery support and societal norms can promote this. Sandall et al’s. (2016) 
Cochrane Review identified that midwifery-led continuity of care decreased 
intervention rates. This has been used to promote policy initiatives, such as the 
establishment of continuity of care teams in all NHS trusts (Cumberlege 2016). A 
change of the maternity care model nationwide which will promote choice, reduce 
interventions and theoretically utilize non-obstetric settings is to be praised, but 
midwives must be supported in providing quality care to women. Well publicised 
concerns regarding midwifery care (Kirkup 2015) has resulted in a focus on public 
safety. The subsequent withdrawal of midwifery supervision and absence of 
midwifery leadership within the NMC (RCM 2020) may have resulted in a midwifery 
culture where midwives have been exposed to physiological birth, yet do not feel 
supported to promote it. However, the appointment of a Chief Midwifery Officer 
aiming to refresh the perception of midwifery (NHS England 2019), may assist in 
changing this with positive leadership. Additionally, a well-publicised Chief Midwifery 
Officer may promote a change in societal norms surrounding childbirth.  
Teijlingen et al. (2009) suggest high-income countries separate birth from normal life, 
which reduces understanding of physiology and results in acceptance that birth, as 
portrayed by the mass media, is dangerous and requires technology. This is 
supported by De Benedictis et al’s. (2018) content analysis of a popular maternity 
television series that reported 77% of births depicted a procedure occurring, of which 
91% did not show facilitation of choice. Whilst there is no specific reference to labour 
augmentation, the study highlights media influences on childbirth. It could be 
theorised that socio-cultural norms surrounding childbirth and depicted in the media 
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could be one of the challenges in preventing TMTS. If it is continually conveyed to 
women that physiological birth is a rare occurrence and consent is not required, they 
may be easily accepting of labour augmentation.  
 
Conclusion 
Overall, it is apparent there are global inconsistencies and evidence of extensive use 
of oxytocin for labour augmentation, therefore it is necessary to consider how this 
can be reduced. The immediate and long-term effects are not always understood or 
appreciated by maternity services, which has impacted true informed choice.  
Although it is understandable that the focus of the SDGs tend to concentrate on 
maternal mortality rate in low-income countries, the UK should not be complacent. 
Extensive research should be carried out into the long-term effects of the UK 
oxytocin administration regimens, which could contribute to international research 
exploring progress and dystocia in physiological birth. Without stronger evidence, 
robust guidelines cannot be produced and used effectively by clinicians or women. 
The changing of educational standards and appointment of a midwifery leader 
should be the impetus for a renewed focus on physiological birth; students and 
qualified midwives need to be supported in experiencing and promoting this. Finally, 
there should be a concerted public health initiative to educate women on the benefits 
of physiological birth and risks of seemingly innocuous interventions. It is important 
to acknowledge the limitations of this paper which warrant further consideration, 
including: the risk discourse, obstetric education and ethnicity, which will be essential 
to prevent harm to mothers and infants.  
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Augmentation of labour is sometimes necessary for the health and wellbeing of 
mother and foetus, however it is essential that practitioners have an awareness of 
the iatrogenic impact of oxytocin and the contributory factors that increase its use. In 
order to ensure equality, women deserve the right to make choices based on strong 
evidence, with care provided by practitioners who can optimise physiology, otherwise 





How do you provide informed choice for labour augmentation? 
Do you feel that there is sufficient support to challenge unnecessary intervention? 
Is physiological birth always respected within your trust? 
Has the partogram helped or hindered you in providing respectful care? 
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